(AFX UK Focus) 2010-03-18 14:21 US FDA staff: may need wider eczema caution for kids
WASHINGTON, March 18 (Reuters) – Novartis AG and Astellas Pharma eczema drugs may need their warning labels expanded after dozens of new reported cases of cancer and infection in children, U.S. Food and Drug Administration staff said in documents released on Thursday. Agency scientists said 46 cancer cases and 71 infection cases have been reported in patients aged 16 and younger from 2004 to …

Read more on Interactive Investor